Dillon & Associates’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q4 | – | Sell |
-2,750
| Closed | -$217K | – | 72 |
|
|
2016
Q3 | $217K | Sell |
2,750
-25
| -0.9% | -$1.97K | 0.1% | 68 |
|
|
2016
Q2 | $230K | Sell |
2,775
-250
| -8% | -$20.7K | 0.11% | 67 |
|
|
2016
Q1 | $278K | Buy |
3,025
+150
| +5% | +$13.8K | 0.13% | 61 |
|
|
2015
Q4 | $290K | Hold |
2,875
| – | – | 0.14% | 58 |
|
|
2015
Q3 | $282K | Hold |
2,875
| – | – | 0.14% | 61 |
|
|
2015
Q2 | $336K | Sell |
2,875
-25
| -0.9% | -$2.92K | 0.16% | 56 |
|
|
2015
Q1 | $284K | Hold |
2,900
| – | – | 0.14% | 58 |
|
|
2014
Q4 | $273K | Sell |
2,900
-50
| -2% | -$4.71K | 0.13% | 59 |
|
|
2014
Q3 | $313K | Hold |
2,950
| – | – | 0.16% | 56 |
|
|
2014
Q2 | $244K | Buy |
2,950
+100
| +4% | +$8.27K | 0.13% | 57 |
|
|
2014
Q1 | $202K | Hold |
2,850
| – | – | 0.11% | 60 |
|
|
2013
Q4 | $214K | Buy |
+2,850
| New | +$214K | 0.12% | 58 |
|